ArticleBlood2021

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.

Bijal D Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.